Axitinib is used to treat advanced renal cell carcinoma (RCC) in patients whose prior treatment has been unsuccessful.
Detailed Use of Axitinib
Axitinib is a medication specifically used in the treatment of a particular type of cancer. Here’s a breakdown:
-
Primary Use: Axitinib is used alone to treat advanced renal cell carcinoma (RCC). According to the provided reference, RCC is a type of cancer that begins in the cells of the kidneys.
-
Treatment Context: It is prescribed for individuals whose RCC has progressed and who have not responded positively to other medications.
In summary, Axitinib is a targeted therapy for advanced kidney cancer, specifically used after other treatments have failed.
